Cargando…
晚期肺腺癌靶向耐药后小细胞癌转化2例并文献复习
Treatment of advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation with EGFR-tyrosine kinase inhibitors (EGFR-TKIs) can achieve good disease control, but it will inevitably produce drug resistance. About 3%-10% of the resistance mechanism is small...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720681/ https://www.ncbi.nlm.nih.gov/pubmed/36419397 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.41 |